Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
International Journal of Medicinal Mushrooms
Facteur d'impact: 1.423 Facteur d'impact sur 5 ans: 1.525 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimer: 1521-9437
ISSN En ligne: 1940-4344

Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushr.v6.i3.20
12 pages

Chemopreventive and Tumoricidal Properties of Ling Zhi Mushroom Ganoderma lucidum (W.Curt.: Fr.)Lloyd (Aphyllophoromycetideae). Part II. Mechanism Considerations (Review)

Yihuai Gao
Institute of Food, Nutrition and Human Health, Massey University; Landcare Research, Private Bag 92170, Auckland, New Zealand
Shufeng Zhou
Division of Pharmacy, School of Life Sciences, Faculty of Science, Queensland University of Technology, Australia; Department of Pharmacy, Faculty of Science, National University of Singapore; University of South Florida FL 33612, USA


We have demonstrated accumulating evidence from preclinical (animals) and clinical studies that has indicated the cancer-preventive and anticancer activities of Ling Zhi Mushroom (Ganoderma lucidum) in Part I. This part highlights the possible underlying mechanisms involved. Data from a recent clinical study in cancer patients showed Ganopoly (a crude G. lucidum polysaccharide extract) enhanced host immune function including increased activity of effector cells including T lymphocytes, macrophages, and natural killer cells, although striking objective antitumor responses were not observed. Currently available data from a number of in vitro and in vivo studies suggests that the cancer preventive and tumoricidal properties of G. lucidum might be ascribed to its ability to enhance the host's immune functions, antioxidative and radical-scavenging effects, inhibition of metabolic activation and enhancement detoxification of carcinogens, and direct cytotoxicity. The major active constituents from G. lucidum may also exert chemopreventive and tumoricidal effects by antiproliferation and modulation of signaling transduction molecules and induction of cell-cycle arrest and apoptosis. Other mechanisms, such as anti-angiogenesis, antipromotion, and antiprogression, might also play a role. Although G. lucidum may represent a practical and promising approach for cancer prevention and cancer treatment, further studies are needed to explore the underlying mechanisms involved and identify unrevealed molecular targets.

Articles with similar content:

Clinical Trials for Medicinal Mushrooms: Experience with Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Lingzhi Mushroom)
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 1&2
Yihuai Gao, Eli Chan, Shufeng Zhou
Hepatoprotective Activity and the Mechanisms of Action of Ganoderma lucidum (Curt.:Fr.) P. Karst. (Ling Zhi, Reishi Mushroom) (Aphyllophoromycetideae) (Review)
International Journal of Medicinal Mushrooms, Vol.5, 2003, issue 2
Yihuai Gao, Min Huang, Zhi-Bin Lin, Shufeng Zhou
Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors
Forum on Immunopathological Diseases and Therapeutics, Vol.3, 2012, issue 2
Chinthalapally V. Rao, Naveena B. Janakiram
Screening and Isolation for Anti-hepatofibrotic Components from Medicinal Mushrooms using TGF-(β1−induced Live Fibrosis in Hepatic Stellate Cells
International Journal of Medicinal Mushrooms, Vol.16, 2014, issue 6
Hongyu Xu, Zhenming Lu, Yan Geng, Zheng-Hong Xu, Jing Wang, Minfeng Xie, Jin-Song Shi
Aberrant B-Raf Signaling in Human Cancer − 10 Years from Bench to Bedside
Critical Reviews™ in Oncogenesis, Vol.17, 2012, issue 1
Michael Roring, Tilman Brummer